Sex and Drugs

Did 20th-century pharmaceutical and technological advances shape modern sexual behaviors?

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

LOVE-IN: Did pharmaceutical advances fuel the 20th century’s sexual revolution?© OSTILL/ISTOCKPHOTO.COMThe sexual revolution of the 1960s unleashed women’s sexuality and shifted their sexual behaviors away from baby-making into the realms of pleasure, love, and self-expression. So goes popular opinion, anyway. For many years, as society has looked back upon that formative decade, the prevailing assumption has been that “The Pill”—the oral hormonal combination approved by the U.S. Food and Drug Administration for female contraception in 1960—was the spark that lit the fire.

“That’s an exaggeration,” says Linda Gordon, a historian at New York University. Elaine Tyler May, a professor of American studies and history at the University of Minnesota, concurs. Despite the widespread belief, “there’s no evidence that the birth control pill caused the sexual revolution.” The scant scientific evidence that exists regarding the sexual attitudes and behaviors of the earlier 20th century paints quite a different picture—one in which the roots of the sexual revolution reach back decades before women starting popping the pill in the 1960s.

The pharmaceutical advances of the 20th century fell into the lap of a culture primed to take advantage of them.

Gordon points out that birth control methods started growing steadily in popularity among American women in the 1910s. After ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies